{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:17:22Z","timestamp":1782371842225,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Burkitt's lymphoma (BL) has worldwide variations in incidence that are related to the age of Epstein-Barr virus (EBV) infection. This study examined the age-specific incidence rate (ASIR) of BL and community EBV seropositivity in Iraqi Kurdistan and compared results with data from countries tabulated in the International Incidence of Childhood Cancer volume 3 (IICC-3).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The ASIR (95% confidence intervals) of BL in Sulaimani Governorate of Iraqi Kurdistan were calculated for the years 2010\u20132020. Specimens from 515 outpatients were tested for IgG and IgM antibodies to EBV viral capsid antigen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In Sulaimani, 84% of BL occurred under 20 years of age, with an ASIR of 6.2 (4.7\u20137.7) per million children. This ASIR was not significantly different than that of Egypt, Morocco, Israel, Spain, or France. It was slightly higher than the ASIR of the United States, the United Kingdom, and Germany and markedly higher than for Asia and South Africa. In Africa and much of Asia, early childhood EBV exposure predominates, with nearly all children being infected by 5 years of age. In Sulaimani, just over 50% of children were EBV seropositive at 3 years old and 90% seropositivity was reached at 15 years of age. In Europe and North America, seropositivity is commonly delayed until adolescence or young adulthood and adult predominates over childhood BL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the Middle East, childhood BL is relatively common and adult BL is rare. In Sulaimani, EBV seropositivity increases progressively throughout childhood and reaches 92% at mid-adolescence. This may reflect the Mid East more widely. We suggest that the high childhood and low adult BL rates may be a regional effect of a pattern of EBV exposure intermediate between early childhood and adolescent and young adult infections.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13027-022-00452-0","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:48:42Z","timestamp":1659095322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epstein-Barr virus and Burkitt\u2019s lymphoma. Associations in Iraqi Kurdistan and twenty-two countries assessed in the International Incidence of Childhood Cancer"],"prefix":"10.1186","volume":"17","author":[{"given":"Dana N.","family":"Muhealdeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Shwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafil T.","family":"Yaqo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemin A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryar O.","family":"Muhammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawa M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Hughson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"452_CR1","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1182\/blood.V93.2.758","volume":"93","author":"DH Wright","year":"1999","unstructured":"Wright DH. What is Burkitt\u2019s lymphoma and when is it endemic. Blood. 1999;93:758.","journal-title":"Blood"},{"key":"452_CR2","first-page":"1397","volume":"60","author":"G Brady","year":"2007","unstructured":"Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007;60:1397\u2013402.","journal-title":"J Clin Pathol"},{"key":"452_CR3","doi-asserted-by":"publisher","first-page":"20160271","DOI":"10.1098\/rstb.2016.0271","volume":"372","author":"C Shannon-Lowe","year":"2017","unstructured":"Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372:20160271.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"452_CR4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.24934","volume":"126","author":"SM Mbulaiteye","year":"2010","unstructured":"Mbulaiteye SM, Anderson WF, Bahtia K, Rosenberg PS, Linet MS, Devesa SS. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973\u20132005. Int J Cancer. 2010;126:1732\u20139.","journal-title":"Int J Cancer"},{"key":"452_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2141.2011.08877.x","volume":"156","author":"DC Linch","year":"2012","unstructured":"Linch DC. Burkitt lymphoma in adults. Br J Haematol. 2012;156:693\u2013703.","journal-title":"Br J Haematol"},{"key":"452_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13027-019-0236-7","volume":"14","author":"L Hammerl","year":"2019","unstructured":"Hammerl L, Colombet M, Rochfort R, Ogwang DM, Parkin DM. The burden of Burkitt lymphoma in Africa. Infect Agent Cancer. 2019;14:17.","journal-title":"Infect Agent Cancer"},{"key":"452_CR7","doi-asserted-by":"publisher","DOI":"10.4102\/sajo.v4i0.93","volume":"4","author":"E Musekwa","year":"2020","unstructured":"Musekwa E, Chapanduka ZC, Bassa F, Kruger M. An 8-year retrospective study of adult and pediatric Burkitt\u2019s lymphoma at Tygerberg Hospital, South Africa. S Afr J Oncol. 2020;4: a93.","journal-title":"S Afr J Oncol"},{"key":"452_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/1097-0142(19951001)76:7<1245::AID-CNCR2820760723>3.0.CO;2-D","volume":"76","author":"N Anwar","year":"1995","unstructured":"Anwar N, Kingma DW, Bloch AR, Mourad M, Raffeld M, Franklin J, Magrath I, el Bolkainy N, Jaffe ES. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt\u2019s lymphoma from Egypt. Cancer. 1995;76:1245\u201352.","journal-title":"Cancer"},{"key":"452_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JGO.19.11000","volume":"5","author":"RT Yaqo","year":"2019","unstructured":"Yaqo RT, Jalal SD, Ghafour KJ, Hassan HA, Hughson MD. Non-Hodgkin lymphoma in the Middle East is characterized by low incidence rates with advancing age. J Glob Oncol. 2019;5:1\u201310.","journal-title":"J Glob Oncol"},{"key":"452_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27399","volume":"65","author":"S Uccini","year":"2018","unstructured":"Uccini S, Al-Jadiri MF, Cippitelli C, Talerico C, Scarpino S, Al-Darraji AF, Al-Badri SAF, Alsaadawi AR, Al-Hadad SA, Ruco L. Burkitt lymphoma in Iraqi children: a distinctive form of sporadic disease with high incidence of EBV+ cases and more frequent expression of MUM1\/IRF4 in cases with head and neck presentation. Pediatr Blood Cancer. 2018;65: e27399.","journal-title":"Pediatr Blood Cancer"},{"key":"452_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/PAS.0000000000000332","volume":"39","author":"A Satou","year":"2015","unstructured":"Satou A, Asano N, Nakazawa A, Osumi T, Tsurusawa M, Ishiguro A, Elsayed AA, Nakamura N, Ohshima K, Kinoshita T, Nakamura S. Epstein-Barr virus (EBV)-positive sporadic Burkitt lymphoma. An age-related lymphoproliferative disorder? Am J Surg Pathol. 2015;39:227\u201335.","journal-title":"Am J Surg Pathol"},{"key":"452_CR12","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.10.010404","volume":"10","author":"JR Winter","year":"2020","unstructured":"Winter JR, Jackson C, Lewis JE, Taylor GS, Thomas OG, Stagg HR. Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: a systematic review of the literature. J Glob Health. 2020;10: 010404.","journal-title":"J Glob Health"},{"key":"452_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","volume":"72","author":"JR Kerr","year":"2019","unstructured":"Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72:651\u20138.","journal-title":"J Clin Pathol"},{"key":"452_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064921","volume":"8","author":"JB Dowd","year":"2013","unstructured":"Dowd JB, Palermo T, Brite J, McDade TW, Aletto A. Seroprevalence of Epstein-Barr virus infection in US children ages 6\u201319, 2003\u20132010. Plos One. 2013;8: e64921.","journal-title":"Plos One"},{"key":"452_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189033","volume":"12","author":"MK Smatti","year":"2017","unstructured":"Smatti MK, Yassine HM, AbuOdeh R, AlMarawani A, Taleb SA, Althani AA, Nasrallah GK. Prevalence and molecular profiling of Epstein-Barr virus (EBV) among healthy blood donors from different nationalities in Qatar. Plos One. 2017;12: e0189033.","journal-title":"Plos One"},{"key":"452_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.26719\/2017.23.12.821","volume":"23","author":"E Farid","year":"2017","unstructured":"Farid E, Al-Biltagi M. Trend and seroprevalence of Epstein-Barr virus in Bahrain; 2001\u20132015. East Mediterr Health J. 2017;23:821\u20139.","journal-title":"East Mediterr Health J"},{"key":"452_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2019.100641","volume":"34","author":"S Sharifipour","year":"2020","unstructured":"Sharifipour S, Davoodi Rad K. Seroprevalence of Epstein-Barr virus among children and adults in Tehran Iran. New Microbes New Infect. 2020;34: 100641.","journal-title":"New Microbes New Infect"},{"key":"452_CR18","unstructured":"International Incidence of Childhood Cancer. Volume III. International Agency for Research on Cancer. World Health Organization; 2021 https:\/\/iicc.iarc.fr\/results\/, Last accessed 11\/14\/2021."},{"key":"452_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/bjc.1984.78","volume":"49","author":"Y Ladjadj","year":"1984","unstructured":"Ladjadj Y, Philip T, Lenoir GM, Tazerout FZ, Bendisari K, Boukheloua R, Biron P, Brunat-Mentigny M, Aboulola M. Abdominal Burkitt-type lymphoma in Algeria. Br J Cancer. 1984;49:503\u201312.","journal-title":"Br J Cancer"},{"key":"452_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jiph.2018.05.005","volume":"11","author":"M El-Amrani-Joutey","year":"2018","unstructured":"El-Amrani-Joutey M, Jiminez-Garcia R, Linares-Garcia-Valdecasas R, Palomar-Gallego MA, Jimenez-Trujillo I, Lopez-de-Andres A, Vasquez-Vasquez L. Infection by Epstein-Barr virus in Fez (Morrocco). Prevalence and predictors of positivity in nasophayngeal cancer. J Infect Pub Health. 2018;11:807\u201311.","journal-title":"J Infect Pub Health"},{"key":"452_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/10428190109057940","volume":"40","author":"N Peylan-Ramu","year":"2001","unstructured":"Peylan-Ramu N, Diment J, Krichevsky S, Ben-Yehuda D, Bhatia K, Magrath IT. Expression of EBV encoded nuclear small non-polyadenylated mRNA (EBER) molecules in 32 cases of childhood Burkitt\u2019s lymphoma from Isreal. Leuk Lymphoma. 2001;40:405\u201311.","journal-title":"Leuk Lymphoma"},{"key":"452_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.annepidem.2012.06.099","volume":"22","author":"H Levine","year":"2012","unstructured":"Levine H, Balicer RD, Rozhavski V, Halperin T, Shreberk M, Davidovich N, Huerta-Hartal M, Ankol OE. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults. Ann Epidemiol. 2012;22:783\u20138.","journal-title":"Ann Epidemiol"},{"key":"452_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/10428199409049685","volume":"14","author":"AO Cavdar","year":"1994","unstructured":"Cavdar AO, Yavuz G, Babacan E, Gozdasoglu S, Unal E, Ertem U, Pamir A, Yucesan S, Gokcora H, Uluoglu O, Ikinciogullari A. Burkitt\u2019s lymphoma in Turkish children: clinical, viral (EBV) and molecular studies. Leuk Lymphoma. 1994;14:323\u201330.","journal-title":"Leuk Lymphoma"},{"key":"452_CR24","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2141.2012.09027.x","volume":"156","author":"V Walusansa","year":"2012","unstructured":"Walusansa V, Okuku F, Orem J. Burkitt lymphoma in Uganda, the legacy of Denis Burkitt and an update on the disease status. Br J Haematol. 2012;156:757\u201360.","journal-title":"Br J Haematol"},{"key":"452_CR25","doi-asserted-by":"publisher","first-page":"235615","DOI":"10.4303\/ajpm\/235615","volume":"2","author":"GE Enow-Orock","year":"2013","unstructured":"Enow-Orock GE, Tchatchoua B, Koki NP. Burkitt\u2019s lymphoma in Cameroon: A review of 300 cases in two referral Health facilities in Yaounde. Afr J Pathol Microbiol. 2013;2:235615.","journal-title":"Afr J Pathol Microbiol"},{"key":"452_CR26","first-page":"158","volume":"5","author":"C Mabilangan","year":"2020","unstructured":"Mabilangan C, Burton C, O\u2019Brien S, Plitt S, Eurich D, Preiksaitis J. Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein-Barr virus in Canada: a cross-sectional study. J Assoc Medical Microbiol Infect Disease Canada. 2020;5:158\u201376.","journal-title":"J Assoc Medical Microbiol Infect Disease Canada"},{"key":"452_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3747\/co.27.5775","volume":"27","author":"SF Roy","year":"2020","unstructured":"Roy SF, Ghazawi FM, Le M, Lagace F, Roy CF, Rahme E, Savin E, Zubarev A, Sasseville D, Popradi G, Litvinov IV. Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemic. Curr Oncol. 2020;27:83\u20139.","journal-title":"Curr Oncol"},{"key":"452_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/bjh.15229","volume":"181","author":"P Karimi","year":"2018","unstructured":"Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN, Mbulaiteye SM. Risk factors for Burkitt\u2019s lymphoma: a nested case-control study in the UK clinical practice research datalink. Brit J Haematol. 2018;181:505\u201314.","journal-title":"Brit J Haematol"},{"key":"452_CR29","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","volume":"20","author":"A Kuri","year":"2020","unstructured":"Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middledorp J, Giovannoni G, Dobson R. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health. 2020;20:912.","journal-title":"BMC Public Health"},{"key":"452_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","volume":"91","author":"S Abrahamyan","year":"2020","unstructured":"Abrahamyan S, Eberspacher B, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Schroeder C, Gruter T, Tackenberg B, Paul F, Then-Bergh F, Kumpfel T, Weber F, Stangel M, Bayas A, Wildemann B, Heesen C, Zetti U, Warnke C, Antony G, Hessler N, Wiendl H, Bittner S, Hemmer B, Gold R, Salmen A, Ruprecht K, German Competence Network Multiple Sclerosis (KKNMS). Complete Epstein-virus seropositivity in a large cohort of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2020;91:681\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"452_CR31","doi-asserted-by":"publisher","first-page":"e0175574","DOI":"10.1371\/journal.pone.0175574","volume":"12","author":"G Fourcade","year":"2017","unstructured":"Fourcade G, Germi R, Guerber F, Lupo J, Baccard M, Seigneurin A, Semenova T, Morand P, Epaulard O. Evolution of EBV seroprevalence and primary infection in a French hospital and a city laboratory network, 2000\u20132016. Plos One. 2017;12:e0175574.","journal-title":"Plos One"},{"key":"452_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-9378-9-34","volume":"9","author":"G Pannone","year":"2014","unstructured":"Pannone G, Zamparse R, Pace M, Pedicillo MC, Cagiano S, Somma P, Errico ME, Donofrio V, Franco R, De Chiara A, Aquino G, Bucci P, Bucci E, Santoro A, Bufo P. The role of EBV in the pathogenesis of Burkitt\u2019s lymphoma: an Italian hospital based survey. Infect Agent Cancer. 2014;9:34.","journal-title":"Infect Agent Cancer"},{"key":"452_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000496828","volume":"62","author":"G Franci","year":"2019","unstructured":"Franci G, Crudele V, Della Rocca MT, Melardo C, Chianese A, Finamore E, Bencivenga F, Astori R, Vitiello M, Galdiero E, Galdiero M. Epstien-Barr virus seroprvalence at the University Hospital Luigi Vanvitelli of Naples from 2007\u20132017. Intervirology. 2019;62:15\u201322.","journal-title":"Intervirology"},{"key":"452_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1157\/13098571","volume":"25","author":"M Pariente","year":"2007","unstructured":"Pariente M, Bartolome J, Lorente S, Crespo MD. Distribucion por edad de los patrones serologicos de infeccion por el virus de Epstein Barr: revision de resultados de un laboratorio de diagnostico. Enferm Infecc Microbiol Clin. 2007;25:108\u201310.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"452_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1827.2006.01936.x","volume":"56","author":"K Takeuchi","year":"2006","unstructured":"Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, Fukayama M, Mori S. Prevalence of Epstein-Barr virus in Japan: Trends and future prediction. Pathol Int. 2006;56:112\u20136.","journal-title":"Pathol Int"},{"key":"452_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/PAS.0000000000000804","volume":"41","author":"A Satou","year":"2017","unstructured":"Satou A, Asano N, Kato S, Elsayed AM, Nakamura N, Miyoshi H, Ohshima K, Nakamura S. Prognostic impact of MUM1\/IRF4 expression in Burkitt lymphoma (BL). A reappraisal of 88 BL patients in Japan. Am J Surg Pathol. 2017;41:389\u201395.","journal-title":"Am J Surg Pathol"},{"key":"452_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017641","volume":"98","author":"J Sim","year":"2019","unstructured":"Sim J, Takayama T, Cho J, Kim SJ, Kim WS, Ree HJ, Ko HY. Changing trends in lymphoid neoplasms in South Korea: analysis of 8615 cases from a single institution, 1997\u20132016: an observational study. Medicine. 2019;98: e17641.","journal-title":"Medicine"},{"key":"452_CR38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00428-005-1277-4","volume":"447","author":"DH Kim","year":"2005","unstructured":"Kim DH, Ko YH, Suh Y, Koo HH, Huh JR, Lee WK. Characteristics of Epstein-Barr virus-associated childhood non-Hodgkin\u2019s lymphoma in the Republic of Korea. Virchows Arch. 2005;447:593\u20136.","journal-title":"Virchows Arch"},{"key":"452_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099857","volume":"9","author":"G Xiong","year":"2014","unstructured":"Xiong G, Zhang B, Huang M, Zhou H, Chen L, Fen Q, Luo X, Lin H, Zeng Y. Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence. Plos One. 2014;9: e99857.","journal-title":"Plos One"},{"key":"452_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018438","volume":"99","author":"X Yang","year":"2020","unstructured":"Yang X, Huang Q, Li A, Chen Y, Xu W, Li J, Wang Y, Fang Y. A long-term retrospective study on sporadic Burkitt lymphoma in Chinese population. Medicine. 2020;99: e18438.","journal-title":"Medicine"},{"key":"452_CR41","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.7314\/APJCP.2015.16.17.7583","volume":"16","author":"R Suntornlohanakul","year":"2015","unstructured":"Suntornlohanakul R, Wanlapakorn N, Vongpunsawad S, Thongmee T, Chansaenroj J, Poovorawan Y. Seroprevalence of anti-EBV IgG among various age groups from Khon Kaen Province Thailand. Asian Pac J Cancer Prev. 2015;16:7583\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"452_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmv.1890150103","volume":"15","author":"AR Venkitaraman","year":"1985","unstructured":"Venkitaraman AR, Lenoir GM, John TJ. The seroepidemiology of infection due to Epstein-Barr virus in Southern India. J Med Virol. 1985;15:11\u20136.","journal-title":"J Med Virol"},{"key":"452_CR43","unstructured":"Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. GPE discussion paper series: No. 31. World Health Organization; 2001."},{"key":"452_CR44","unstructured":"Office of Public Health Assessment: Confidence intervals in public health. Utah Department of Health. https:\/\/ibis.health.utah.gov"},{"key":"452_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.4459","volume":"235","author":"M Vockerodt","year":"2015","unstructured":"Vockerodt M, Yap L-F, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol. 2015;235:312\u201322.","journal-title":"J Pathol"},{"key":"452_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fonc.2018.00211","volume":"8","author":"MK Smatti","year":"2018","unstructured":"Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update. Front Oncol. 2018;8:211.","journal-title":"Front Oncol"},{"key":"452_CR47","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMe068075","volume":"354","author":"NL Harris","year":"2006","unstructured":"Harris NL, Horning SJ. Burkitt\u2019s lymphoma-the message from microarrays. N Engl J Med. 2006;354:2495\u20138.","journal-title":"N Engl J Med"},{"key":"452_CR48","unstructured":"Global Cancer Observatory. International Agency for Research on Cancer. Cancer Today. https:\/gco.iarc.fr\/today\/home"},{"key":"452_CR49","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12882-021-02486-9","volume":"22","author":"AA Ali","year":"2021","unstructured":"Ali AA, Almukhtar SE, Abd KH, Saleem ZSM, Sharif DA, Hughson MD. The causes and frequency of kidney allograft failure in a low-resource setting: observational data from Iraqi Kurdistan. BMC Nephrol. 2021;22:272.","journal-title":"BMC Nephrol"},{"key":"452_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","volume":"8","author":"Z Al-Mansour","year":"2013","unstructured":"Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLPD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013;8:173\u201388.","journal-title":"Curr Hematol Malig Rep"},{"key":"452_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/microorganisms9020338","volume":"9","author":"M Al-Awadhi","year":"2021","unstructured":"Al-Awadhi M, Ahmad S, Iqbal J. Current status and epidemiology of malaria in the Middle East region and beyond. Microorganisms. 2021;9:338.","journal-title":"Microorganisms"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-022-00452-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T03:40:09Z","timestamp":1700883609000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-022-00452-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["452"],"URL":"https:\/\/doi.org\/10.1186\/s13027-022-00452-0","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the Declaration of Helsinki. The Ethics Committees of the Sulaimami Department of Health and Hiwa Cancer Hospital gave permission for the research. The Ethics Committees' approval included the use of serum samples. The serum samples were to be discarded and were de-identified by name. The study otherwise reviewed existing reports with no additional patient intervention and was considered exempt from informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest. The manuscript has not been previously published in whole or in part.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}